Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Cefalexin; Dihydrostreptomycin sulfate
Bimeda Animal Health Limited
QJ51RD01
Cefalexin; Dihydrostreptomycin sulfate
500/500 mg/syringe
Intramammary suspension
POM: Prescription Only Medicine as defined in relevant national legislation
cefalexin, combinations with other antibacterials
Authorised
2008-02-15
1. NAME OF THE VETERINARY MEDICINAL PRODUCT CEEMAST Dry Cow Intramammary Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each syringe contains: ACTIVE SUBSTANCES: Cefalexin 500 mg Dihydrostreptomycin 500 mg (as Dihydrostreptomycin Sulphate) EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS Cera alba Liquid paraffin Smooth, pale pink or pale yellow suspension. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle (dry cows). 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES For the treatment of sub clinical mastitis infection present at drying off in cows and to assist in preventing new infections occurring during the dry period. 3.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substances or to any of the excipients. Do not use in lactating cows. Do not use within 40 days of the estimated calving date. 3.4 SPECIAL WARNINGS None. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: Use of the product should be based on identification and susceptibility testing of the target pathogen(s). If this is not possible, therapy should be based on epidemiological information and knowledge of susceptibility of the target pathogens at farm level, or at local/regional level. Use of the product should be in accordance with official, national and regional antimicrobial policies. An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG category) should be used for first line treatment where susceptibility testing suggests the likely efficacy of this approach. Narrow spectrum antibiotic therapy with a lower risk of antimicrobial resistance selection should be used for first line treatment where susceptibility testing suggests the likely efficacy of this approach. The feeding of waste milk containing residues of cefalexin to calves should be avoided up to the end of the milk withdrawal period (except during the colostral phase), because it could select antimicrobial-resistant bacteria within the intestinal microbiota of the Прочитать полный документ